Symrise AG Makes Minority Investment in Bonumose

Summa Equity Acquires Majority Stake in Nutris

September 3, 2024

Food & Beverage

Impact investor Summa Equity has acquired a majority stake in Nutris, a Croatian plant-based protein ingredients manufacturer founded in 2019. The investment will support scaling Nutris’s manufacturing capacity and R&D to expand production of fava-bean protein isolates and other plant-based ingredients for food, sports nutrition and dairy/meat alternative markets.

Symrise Acquires Giraffe Foods from Graham Partners

January 6, 2022

Food & Beverage

Symrise AG has acquired Giraffe Foods (headquartered in Mississauga, Ontario) from Graham Partners and the founding Powell family. Giraffe Foods is a custom developer and manufacturer of sauces, marinades, dips and dressings; the acquisition expands Symrise's custom taste solutions and forward-integrates its Flavor & Nutrition capabilities in North America.

Lesaffre Acquires 70% Stake in Biorigin from Zilor

October 4, 2024

Food & Beverage

Lesaffre has agreed to acquire a 70% majority stake in Biorigin, a yeast-derivatives business unit of Brazilian agribusiness Zilor, with Zilor retaining a 30% interest. The deal (subject to customary approvals, including CADE) gives Lesaffre control of Biorigin's production footprint in São Paulo (including a plant in Quatá) and is intended to expand Lesaffre's yeast-derivative capabilities and global savory-ingredient supply; the move follows Lesaffre's related collaboration to acquire DSM-Firmenich's yeast-extract go-to-market organization and know-how.

Lesaffre (Agrauxine) Acquires Advanced Biological Marketing (ABM)

May 4, 2021

Agriculture

Lesaffre, through its Agrauxine business unit, has acquired Advanced Biological Marketing (ABM), a Van Wert, Ohio-based developer and manufacturer of biological seed treatments, biostimulants and foliar biopesticides. The deal strengthens Agrauxine's presence and R&D/manufacturing capabilities in the United States and broadens Lesaffre's portfolio in crop bioprotection and bionutrition.

Solabia Agrees to Acquire Mibelle Biochemistry, Seqens Botanical Actives & In-Vitro Diagnostics Activity, and Xebios Group

March 5, 2026

Biotechnology

Solabia, a Paris-headquartered biotech platform focused on natural active ingredients and diagnostics solutions, has agreed to acquire three complementary businesses: Mibelle Biochemistry, Seqens’ Botanical Actives and In-Vitro Diagnostics activity, and Xebios Group. The acquisitions broaden Solabia’s capabilities in natural cosmetic actives and expand its microbiological diagnostics footprint in Europe as the company accelerates its international expansion strategy.

Sumitomo Chemical Makes Strategic Investment in Conagen

March 31, 2020

Biotechnology

Sumitomo Chemical, the global chemical company headquartered in Tokyo, made a strategic growth investment in Greater Boston biotech Conagen to accelerate the company’s synthetic biology research, development, and commercialization of sustainable bio-based chemicals. The partnership aims to combine Sumitomo’s industrial and manufacturing expertise with Conagen’s bio-manufacturing platforms to scale greener chemical production.